4 Biotechs Ready to Kill the Market in 2018 Post author:Sam Post published:December 28, 2017 Post category:BioPharma A look at a few biotechs which should outperform the market in 2018: Source: BioSpace You Might Also Like Job Cuts and Facility Reductions Loom Over SoCal's ImmunoCellular August 23, 2017 Filings Reveal Founder & CEO Buy Adds $570K to Retractable Tech Stake August 30, 2017 Forensic Exam Shows Pattern in 4 Deaths of Sanofi Dengue Vaccine Recipients January 9, 2018
